A 58-year-old with HFrEF (LVEF 25%) is euvolemic on ARNI, beta-blocker, and MRA. eGFR 62; UACR 80 mg/g. Which additional therapy improves HF outcomes ...

Question

A 58-year-old with HFrEF (LVEF 25%) is euvolemic on ARNI, beta-blocker, and MRA. eGFR 62; UACR 80 mg/g. Which additional therapy improves HF outcomes independent of diabetes status?

Accepted Answer

SGLT2 inhibitor

Answer

DPP-4 inhibitor

Answer

Ivabradine only if HR

Answer

Loop diuretic uptitration to maximum

Answer

Non-dihydropyridine calcium channel blocker

us-abim MCQ (SBA): Heart Failure with Reduced Ejection Fraction

A 58-year-old with HFrEF (LVEF 25%) is euvolemic on ARNI, beta-blocker, and MRA. eGFR 62; UACR 80 mg/g. Which additional therapy improves HF outcomes independent of diabetes status?